| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale
|
Rao, Meena P.
|
|
2016
|
176 |
C |
p. 107-113
7 p.
|
article
|
| 2 |
Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation
|
Schnabel, Renate B.
|
|
2016
|
176 |
C |
p. 100-106
7 p.
|
article
|
| 3 |
Cardiovascular health among diverse Hispanics/Latinos: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) results
|
González, Hector M.
|
|
2016
|
176 |
C |
p. 134-144
11 p.
|
article
|
| 4 |
Editorial Board
|
|
|
2016
|
176 |
C |
p. A4-
1 p.
|
article
|
| 5 |
Extended duration dual antiplatelet therapy in patients with myocardial infarction: A study-level meta-analysis of controlled randomized trials
|
Patti, Giuseppe
|
|
2016
|
176 |
C |
p. 36-43
8 p.
|
article
|
| 6 |
Higher mortality among males in takotsubo cardiomyopathy
|
Pant, Sadip
|
|
2016
|
176 |
C |
p. e1-
1 p.
|
article
|
| 7 |
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation
|
Eckman, Mark H.
|
|
2016
|
176 |
C |
p. 17-27
11 p.
|
article
|
| 8 |
Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)
|
Puri, Rishi
|
|
2016
|
176 |
C |
p. 83-92
10 p.
|
article
|
| 9 |
Information for Readers
|
|
|
2016
|
176 |
C |
p. A5-
1 p.
|
article
|
| 10 |
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report
|
Grimfjärd, Per
|
|
2016
|
176 |
C |
p. 78-82
5 p.
|
article
|
| 11 |
Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry
|
Anderson, Lindsay L.
|
|
2016
|
176 |
C |
p. 1-9
9 p.
|
article
|
| 12 |
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
|
|
|
2016
|
176 |
C |
p. 63-69
7 p.
|
article
|
| 13 |
Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: Findings from the Women's Health Initiative
|
Rodriguez, Fatima
|
|
2016
|
176 |
C |
p. 70-77
8 p.
|
article
|
| 14 |
Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study
|
Lopes, Renato D.
|
|
2016
|
176 |
C |
p. 10-16
7 p.
|
article
|
| 15 |
Rebuttal of critique of Progetto Vita survival data
|
Capucci, Alessandro
|
|
2016
|
176 |
C |
p. e7-
1 p.
|
article
|
| 16 |
Response to “Higher mortality among males in takotsubo cardiomyopathy”
|
Khera, Rohan
|
|
2016
|
176 |
C |
p. e3-
1 p.
|
article
|
| 17 |
Shock complicating type A acute aortic dissection: Clinical correlates, management, and outcomes
|
Bossone, Eduardo
|
|
2016
|
176 |
C |
p. 93-99
7 p.
|
article
|
| 18 |
Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial
|
van der Heijden, Liefke C.
|
|
2016
|
176 |
C |
p. 28-35
8 p.
|
article
|
| 19 |
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations
|
De Luca, Leonardo
|
|
2016
|
176 |
C |
p. 44-52
9 p.
|
article
|
| 20 |
Table of Contents
|
|
|
2016
|
176 |
C |
p. A1-A3
nvt p.
|
article
|
| 21 |
Tackling cardiovascular disease in Hispanic/Latinos: Achieving 2020 Goals
|
Ventura, Hector O.
|
|
2016
|
176 |
C |
p. 125-126
2 p.
|
article
|
| 22 |
Temporal trends of single-photon emission computed tomography myocardial perfusion imaging in patients without prior coronary artery disease: A 22-year experience at a tertiary academic medical center
|
Jouni, Hayan
|
|
2016
|
176 |
C |
p. 127-133
7 p.
|
article
|
| 23 |
The nonsense paradigm of rethinking the second link of the chain of survival: “if shock is not advised, wait and do nothing!” Aren’t we condemning our cardiac arrest patients?
|
Ristagno, Giuseppe
|
|
2016
|
176 |
C |
p. e5-e6
nvt p.
|
article
|
| 24 |
The on- and off-target effects of morphine in acute coronary syndrome: A narrative review
|
McCarthy, Cian P.
|
|
2016
|
176 |
C |
p. 114-121
8 p.
|
article
|
| 25 |
The “rise of the rule out”: The SPECTer of cardiac stress imaging
|
Lehman, Elmer Philip
|
|
2016
|
176 |
C |
p. 122-124
3 p.
|
article
|
| 26 |
Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial
|
Blumenthal, James A.
|
|
2016
|
176 |
C |
p. 53-62
10 p.
|
article
|
Journal description